Fundz

Octave Bioscience

MENLO PARK, Calif. · Biotechnology, Healthcare

Octave Bioscience, Inc. is a commercial growth stage precision medicine company pioneering biomarker-driven solutions for neurodegenerative diseases, with an initial focus on Multiple Sclerosis, and Parkinson’s Disease in partnership with the Michael J. Fox Foundation. Octave’s comprehensive testing solutions provide objective, actionable insights to improve disease monitoring, treatment decisions

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
MENLO PARK, Calif.
Employees
83
Industries
Biotechnology, Healthcare
Status
Private
Website
www.octavebio.com
LinkedIn
Company page

Recent activity at Octave Bioscience

Employee benefit plans

Octave Bioscience files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

About Octave Bioscience: questions and answers

What does Octave Bioscience do?

Octave Bioscience, Inc. is a commercial growth stage precision medicine company pioneering biomarker-driven solutions for neurodegenerative diseases, with an initial focus on Multiple Sclerosis, and Parkinson’s Disease in partnership with the Michael J. Fox Foundation. Octave’s comprehensive testing solutions provide objective, actionable insights to improve disease monitoring, treatment decisions

Where is Octave Bioscience headquartered?

Octave Bioscience is headquartered in MENLO PARK, Calif..

How many employees does Octave Bioscience have?

Octave Bioscience has about 83 employees.

What is the latest news on Octave Bioscience?

On Jan 08, 2026, Octave Bioscience Appoints Kirk Stockwood as Senior Vice President, Commercial

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Octave Bioscience across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.